Crispr Therapeutics shares tumble after significant earnings miss
John W. Schlosser, Vice President and President of Terminals at Kinder Morgan , Inc. (NYSE:KMI), recently sold 75,461 shares of the company’s stock. The transactions took place on February 18, 2025, with the shares sold at a weighted average price of $26.6489 each, generating a total of approximately $2,010,952. The sale comes as KMI trades near its 52-week high of $31.48, with the stock showing impressive momentum, having gained over 64% in the past year. According to InvestingPro analysis, KMI currently appears overvalued relative to its Fair Value.
Following the sale, Schlosser retains ownership of 220,681 shares in the company. The price range for these transactions was between $26.56 and $26.77 per share, according to the filing with the Securities and Exchange Commission. InvestingPro data shows KMI has maintained dividend payments for 15 consecutive years, with a current dividend yield of 4.3%. Discover more insights and 10+ additional ProTips about KMI with an InvestingPro subscription, including detailed analysis in the comprehensive Pro Research Report.
In other recent news, Kinder Morgan has received a positive outlook upgrade from S&P Global, affirming its ’BBB’ issuer credit rating. This revision is attributed to the company’s robust balance sheet and strategic growth in its natural gas franchise. The company’s 2025 business plan outlines continued growth, driven by its extensive U.S. natural gas transmission network and significant investments in energy transition projects. Recent developments include ArcLight Capital Partners (WA:CPAP) acquiring a 25% stake in the Gulf Coast Express Pipeline, a move that aligns with increasing power demand needs. Additionally, Kinder Morgan has revised its bylaws to streamline corporate governance and shareholder engagement processes. Stifel analysts have maintained a Hold rating for Kinder Morgan, with a price target of $27, following financial results that slightly missed expectations. The company’s project backlog has increased to $8.1 billion, with plans for annual capital expenditures of $2.5 billion over the next few years. Furthermore, the acquisition of Outrigger Energy II’s Bakken system for $640 million is expected to positively impact earnings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.